10X FUND, L.P. sold 0.5% of their position (30.68K shares) of GALECTIN THERAPEUTICS INC on the open market
Open‑market sale worth $204.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/18/2025ACC: 0001493152-25-028303
-54.68K
Net shares
Net seller
$204.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
54.68K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−24K
Price / share
—
Trade value
—
% of position
0.4%
11/24/2025
5.67M→5.65M
Common Stock
Direct
Shares
−30.68K
Price / share
$6.66
Trade value
$204.34K
% of position
0.5%
12/16/2025
5.65M→5.61M
Total
Net shares
−54.68K
Net value
-$204.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/24/2025 | J · J | −24K | — | — | 0.4% | 5.67M | 5.65M |
| Common Stock Direct | 12/16/2025 | S · Sale | −30.68K | $6.66 | $204.34K | 0.5% | 5.65M | 5.61M |
| Total | −54.68K | -$204.34K | ||||||
Derivative Transactions0
No derivative transactions reported